INSIGHTS ON PHARMACEUTICAL LOGISTICS

• How To Select The Right Fill-Finish CDMO For Phase I–II

  Early‑phase programs require flexible, technically aligned fill‑finish partners. Mid‑sized CDMOs offer a balance of agility, infrastructure, and regulatory maturity suited to Phase I–II needs.

• The Way Forward: Supply Chain Solutions

  Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

• A Temperature-Stable Replacement For Animal Trypsin In Cell Dissociation Applications

  Improve cell dissociation with a gentle, recombinant enzyme. This temperature-stable protease shows dissociation kinetics similar to porcine trypsin but with lower cell toxicity and greater overall purity.

• Manufacturing Made More Robust And Customer-Centric

  Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

• Unlocking The Benefits Of Customs Warehouse For Pharmaceutical Supply Chains

  4/8/2026

  Learn how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  1/23/2025

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• Optimized Processes: A Guide To Lyophilization Cycle Development

  6/25/2024

  Review the essential phases of the lyophilization cycle — freezing, primary drying, and secondary drying — and critical success factors to achieve optimal product quality and stability.

• Cryogenic Storage Of IV Bags For Cell And Gene Therapies

  12/18/2025

  Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.

• Friendshoring: A Strategic Shift In Pharma Supply Chains

  4/11/2025

  To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models.